Drug industry backers pushing for split at FDA (The Washington Times)
faster approvals for new medicines.

Experts: Splitting up FDA could improve food safety, speed drug approvals (Seattle Times)
As momentum builds to rework the nation's food-safety system after a salmonella outbreak linked to peanuts, the drug industry is hoping for a happy side effect: faster approvals for new medicines.

FDA Committee Finds Favorable Profile For Rivaroxaban For DVT And Pulmonary Embolism After Hip/Knee Surgery (Medical News Today)
Ortho-McNeil announced that the U.S. Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee has determined that rivaroxaban, a novel, investigational, oral anticoagulant, has a favorable risk-benefit profile for the prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing hip replacement or knee replacement surgery.